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Particulate air pollution (PM) is associated
with increased risk of hospitalization and
death from cardiovascular disease (Brook et al.
2004; Forastiere et al. 2005; Samet et al.
2000; Schwartz 1999; Zanobetti and
Schwartz 2005), but the mechanisms under-
lying such effects are not fully understood.
Reductions in heart rate variability (HRV), a
noninvasive measure that independently pre-
dicts cardiovascular mortality (Tsuji et al.
1996), have been related to PM exposure, par-
ticularly to fine-particulate air pollution of
< 2.5 µm in aerodynamic diameter (PM2.5)
(Creason et al. 2001; Devlin et al. 2003; Gold
et al. 2000; Holguin et al. 2003; Liao et al.
2005a; Magari et al. 2002; Park et al. 2005;
Pope et al. 2004; Schwartz et al. 2005a).
Animal experiments indicate that reactive
oxygen species (ROS), which have established
relevance in the pathogenesis of cardiovascular
disease (Dhalla et al. 2000), are potential medi-
ators for particle effects on HRV and other car-
diovascular end points (Brook et al. 2004;
Gurgueira et al. 2002; Nel 2005; Rhoden et al.
2004). While animal models can identify
potential mechanisms of particle effects, the
relative importance of these pathways in
humans at lower doses is not clear and may be
determined by examining subjects with geneti-
cally determined differences in oxidative-stress
defenses. In elderly subjects living in the
Boston, Massachusetts, metropolitan area, we
recently showed that PM2.5 levels during the
48 hr before the study were associated with
decreased HRV in individuals with the glu-
tathione S-transferase M1 (GSTM1) deletion,
but had no effect in subjects with GSTM1
present (Schwartz et al. 2005b).
Studies showing the effect of just one
polymorphism are unlikely to correctly repre-
sent the complex etiology of common dis-
eases, and failure to account for gene–gene
interactions in the search for susceptibility
genes has been widely suggested to explain
the persisting difficulties in replicating signifi-
cant findings (Millstein et al. 2006). Particle
exposure induces both heme oxygenase-1
(HMOX-1) and GSTM1 expression through
activation of the genetic antioxidant response
element (ARE) (Li et al. 2004). A high num-
ber of microsatellite (GT)n dinucleotide
repeats in 5´-flanking region may reduce
HMOX-1 inducibility by ROS and has been
associated with increased risk of coronary
artery disease in high-risk groups with
hyperlipidemia, diabetes, or current smoking
(Chen et al. 2002; Kaneda et al. 2002).
Consequently, individuals with a high num-
ber of (GT)n repeats may be more susceptible
to the effects of airborne particles.
We hypothesized that the gene encoding
HMOX-1, which is involved in various aspects
of responses against oxidative stress, may
a) directly modify the effect of ambient PM on
HRV and b) interact with GSTM1 to deter-
mine which subjects are susceptible to airborne
particle effects. To establish the role of the
antioxidant response pathway in determining
the cardiovascular effects of airborne particles,
we examined in the present study the associa-
tion of PM2.5 with HRV in a repeated measure
study of elderly subjects from the Boston met-
ropolitan area, and evaluated how that associa-
tion was affected by genetic variation in the
HMOX-1 and GSTM1 loci.
Materials and Methods
Study population. Our study population con-
sisted of 539 white males from the Normative
Aging Study (NAS), a longitudinal study of
aging established in 1963 by the U.S.
Veterans Administration (Bell et al. 1972).
Between January 2000 and June 2005, all
participants still presenting for examination
(n = 676) were evaluated for HRV. Of these,
137 subjects were excluded because of heart
arrhythmias, measurement time < 3.5 min, or
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BACKGROUND AND OBJECTIVES: We have previously shown that reduced defenses against oxidative
stress due to glutathione S-transferase M1 (GSTM1) deletion modify the effects of PM2.5 (fine-
particulate air pollution of < 2.5 µm in aerodynamic diameter) on heart rate variability (HRV) in a
cross-sectional analysis of the Normative Aging Study, an elderly cohort. We have extended this to
include a longitudinal analysis with more subjects and examination of the GT short tandem repeat
polymorphism in the heme oxygenase-1 (HMOX-1) promoter.
METHODS: HRV measurements were taken on 539 subjects. Linear mixed effects models were fit
for the logarithm of HRV metrics—including standard deviation of normal-to-normal intervals
(SDNN), high frequency (HF), and low frequency (LF)—and PM2.5 concentrations in the 48 hr
preceding HRV measurement, controlling for confounders and a random subject effect.
RESULTS: PM2.5 was significantly associated with SDNN (p = 0.04) and HF (p = 0.03) in all sub-
jects. There was no association in subjects with GSTM1, whereas there was a significant association
with SDNN, HF, and LF in subjects with the deletion. Similarly, there was no association with any
HRV measure in subjects with the short repeat variant of HMOX-1, and significant associations in
subjects with any long repeat. We found a significant three-way interaction of PM2.5 with GSTM1
and HMOX-1 determining SDNN (p = 0.008), HF (p = 0.01) and LF (p = 0.04). In subjects with
the GSTM1 deletion and the HMOX-1 long repeat, SDNN decreased by 13% [95% confidence
interval (CI), –21% to –4%], HF decreased by 28% (95% CI, –43% to –9%), and LF decreased by
20% (95% CI, –35% to –3%) per 10 µg/m3 increase in PM.
CONCLUSIONS: Oxidative stress is an important pathway for the autonomic effects of particles.
KEY WORDS: air particles, air pollution, cardiovascular health, genetic variation, GST, heart rate vari-
ability, HMOX-1, PM2.5. Environ Health Perspect 115:1617–1622 (2007). doi:10.1289/ehp.10318
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missing potential confounding variables or
HMOX-1 data. Among the remaining
539 subjects, GSTM1 data were available for
476 subjects, who had one (n = 314) or two
(n = 162) HRV measurements. In subjects
with multiple HRV measurements, the time
interval between measurements was approxi-
mately 3 years. This study was conducted in
compliance with all applicable requirements
of the U.S. and international regulations
(including institutional review board
approval). All subjects gave written informed
consent prior to the study.
HRV measurement. HRV was measured at
rest during normal breathing for 7 min using a
two-channel (five-lead) ECG monitor
(Trillium 3000; Forest Medical, East Syracuse,
NY) while the subject was seated. Standard
deviation of normal-to-normal intervals
(SDNN), high frequency (HF) (0.15–0.4 Hz),
and low frequency (LF) (0.04 –0.15 Hz) were
computed with a fast Fourier transform using
software (Trillium 3000 PC Companion
Software; Forest Medical) complying with
established guidelines (Task Force of the
European Society of Cardiology and the North
American Society of Pacing and Electro-
physiology 1996). In the analysis, we used the
4 consecutive minutes of ECG reading that
included the lowest number of artifacts.
Air pollution and weather data.
Continuous PM2.5 was measured at a station-
ary monitoring site on the roof of Countway
Library of Harvard University in downtown
Boston using a Tapered Element Oscillating
Microbalance (TEOM; Model 1400A,
Rupprecht & Patashnick Co., East Greenbush,
NY). Meteorologic data was obtained from the
Boston airport weather station. The 48-hr
moving average of PM2.5 before each HRV
measurement was used as the exposure index,
as this exposure period has shown the strongest
association in previous studies (Park et al.
2005).
HMOX-1 and GSTM1 genotyping. The
GSTM1 locus (UniGene Hs.301961;
UniGene 2007a) was amplified at exons 4 and
5 by polymerase chain reaction (PCR) as pre-
viously described to differentiate between the
null polymorphism and the presence of one or
more copies of the gene (Schwartz et al.
2005b). The HMOX-1 (UniGene Hs.517581;
UniGene 2007b) microsatellite (GT)n length
assay was designed per Yamada and coworkers
(Yamada et al. 2000). Briefly, the HMOX-1
locus was amplified by PCR at the 5´ promoter
flanking region containing (GT)n repeats with
primers as described by Yamada, and the sizes
of the PCR products were analyzed with a
laser-based automated DNA sequencer (AB
3100; Applied Biosystems, Foster City, CA).
Although the exact cutoff for HMOX-1 mod-
ulation is still unknown, constructs with
lengths of > 25 repeats showed reduced
HMOX-1 basal promoter activity and
decreased transcriptional upregulation in
response to various stimuli like H2O2 com-
pared with lengths < 25 repeats (Chen et al.
2002; Yamada et al. 2000). In the analysis of
the data, we used the 25-repeat cutoff to cate-
gorize the study subjects in two categories
[< 25 (GT)n repeats in both alleles or ≥ 25
(GT)n repeats in at least one allele] based on
the HMOX-1 microsatellite length.
Statistical analysis. HRV measurements
were log10-transformed to improve normality.
The following potential confounders were cho-
sen a priori and included in the analysis: age,
body mass index (BMI), mean arterial pres-
sure, fasting blood glucose, cigarette smoking
(never/former/current), alcohol consumption
(≥ 2 drinks a day, yes/no), use of beta-blockers,
calcium channel blockers, acetylcholinesterase
(ACE) inhibitors, room temperature, season,
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Table 1. Anthropometric, clinical characteristics, and heart rate variability parameters [mean ± SD or n (%)] of the study population, by GSTM1 polymorphism status
and HMOX-1 microsatellite repeat length.
By GSTM1 and HMOX-1 polymorphisms (n = 476)
All subjects GSTM1 wt GSTM1 null GSTM1 wt GSTM1 null
analyzed for both HMOX-1 HMOX-1 HMOX-1 HMOX-1
All subjects HMOX-1 and GSTM1 < 25 repeatsa < 25 repeatsa ≥ 25 repeatsb ≥ 25 repeatsb
Variable (n = 539) (n = 476) (n = 20) (n = 24) (n = 204) (n = 228)
Age (years) 72.8 ± 6.6 73.0 ± 6.7 72.5 ± 4.8 73. 2 ± 5.9 73.0 ± 6.8 73.1 ± 6.82
BMI (kg/m2) 28.2 ± 4.1 28.0 ± 4.1 27.8 ± 4.7 28.3 ± 3.3 28.1 ± 4.4 28.0 ± 3.90
Systolic blood pressure (mm Hg) 130.6 ± 16.3 130.5 ± 16.7 131.4 ± 16.1 133.8 ± 16.3 129.5 ± 15.7 131.0 ± 17.8
Diastolic blood pressure (mm Hg) 74.9 ± 9.7 74.7 ± 9.7 74.3 ± 8.5 76.3 ± 7.1 74.7 ± 9.7 74.7 ± 10.0
Mean arterial pressure (mm Hg) 93.5 ± 10.6 93.3 ± 10.7 93.3 ± 9.5 95.5 ± 8.6 92.9 ± 10.5 93.4 ± 11.2
Heart rate (beats/min) 70.7 ± 6.8 71.0 ± 6.8 72.0 ± 4.6 70.6 ± 6.5 70.5 ± 6.8 71.2 ± 7.1
Fasting blood glucose (mg/dL) 108.4 ± 28.4 109.2 ± 29.5 108.2 ± 35.8 115.2 ± 32.7 112.2 ± 35.4 105.9 ± 21.5
Total cholesterol (mg/dL) 194.9 ± 36.7 194.8 ± 37.3 187.3 ± 32.9 202.3 ± 37.8 196.7 ± 35.3 192.9 ± 39.3
HDL (mg/dL) 49.5 ± 13.3 49.8 ± 13.3 52.2 ± 15.2 49.4 ± 13.1 49.3 ± 12.5 49.9 ± 13.8
Triglyceride (mg/dL) 131.8 ± 72.2 130.5 ± 72.8 118.4 ± 66.3 125.9 ± 60.2 130.9 ± 67.5 131.8 ± 79.1
Smoking status [n (%)]
Never smoker 165 (30.6) 145 (30.5) 6 (30.0) 5 (20.8) 71 (34.8) 63 (27.6)
Current smoker 27 (5.0) 23 (4.8) 3 (15.0) 2 (8.3) 6 (2.9) 12 (5.3)
Former smoker 347 (64.4) 308 (64.7) 11 (55.0) 17 (70.8) 127 (62.3) 153 (67.1)
Alcohol intake (≥ 2 drinks/day) [n (%)] 102 (18.9) 89 (18.7) 2 (10.0) 4 (16.7) 42 (20.6) 41 (18.0)
Diabetes mellitus, n (%) 80 (14.8) 75 (15.8) 5 (25.0) 6 (25.0) 38 (18.6) 26 (11.4)
CHD history [n (%)] 153 (28.4) 138 (29.0) 5 (25.0) 6 (25.0) 58 (28.4) 69 (30.3)
Stroke history [n (%)] 33 (6.1) 29 (6.1) 1 (5.0) 1 (4.2) 17 (8.3) 10 (4.4)
Hypertension [n (%)] 377 (69.9) 331 (69.5) 14 (70.0) 15 (62.5) 139 (68.1) 163 (71.5)
Use of beta-blocker [n (%)] 181 (33.6) 157 (33.0) 7 (35.0) 5 (20.8) 66 (32.4) 79 (34.7)
Use of Ca channel blocker [n (%)] 70 (13.0) 61 (12.8) 1 (5.0) 2 (8.3) 30 (14.7) 28 (12.3)
Use of ACE inhibitor [n (%)] 112 (20.8) 105 (22.1) 5 (25.0) 2 (8.3) 37 (18.1) 61 (26.8)
Heart rate variabilityc
Log10 SDNN (msec) 1.52 ± 0.25 1.52 ± 0.25 1.53 ± 0.24 1.48 ± 0.21 1.52 ± 0.26 1.53 ± 0.25
Log10 HF (msec2) 1.90 ± 0.65 1.90 ± 0.65 1.84 ± 0.52 1.74 ± 0.58 1.92 ± 0.65 1.92 ± 0.67
Log10 LF (msec2) 2.00 ± 0.53 2.00 ± 0.53 1.99 ± 0.48 1.93 ± 0.48 2.00 ± 0.56 2.01 ± 0.52
Environmental variables
PM2.5d (µg/m3) 11.7 ± 7.8 11.6 ± 7.9 11.9 ± 5.8 12.3 ± 12.2 11.6 ± 7.8 11.5 ± 7.7
Apparent temperatured (°C) 11.1 ± 10.0 10.9 ± 10.0 12.4 ± 9.9 12.6 ± 9.8 10.7 ± 10.2 10.7 ± 9.8
Room temperature (°C) 24.3 ± 1.8 24.3 ± 1.8 25.0 ± 0.9 24.8 ± 1.8 24.3 ± 1.7 24.2 ± 1.9
Abbreviations: LDL, low-density lipoprotein. 
aCarriers of < 25 microsatellite (GT) repeats in both alleles. bCarriers of ≥ 25 microsatellite (GT) repeats in at least one allele. cStandard deviation of SDNN, power in HF (0.15–0.4 Hz) and
LF (0.04–0.15 Hz) computed using a fast Fourier transform algorithm. dAverage of hourly measurements of PM2.5 and apparent temperature during the 48 hr before the HRV measurement.
and 48-hr moving average of outdoor apparent
temperature. Potential nonlinearity between
apparent temperature and HRV was accounted
for using a linear and quadratic term.
Because our data included repeated meas-
ures of HRV for many participants, our data
may lack independence. To deal with this, we
fit a mixed effects model (PROC MIXED in
SAS version 9.0; SAS Institute Inc., Cary,
NC). We assumed:
, [1]
where Yit is the logarithm of HRV in subject
i at time t, b0 is the overall intercept, and ui is
the separate random intercept for subject i. In
the above, X1—Xp are the covariates measured
at each of the visits in which the HRV meas-
urements were taken. This captures the corre-
lation among measurements within the same
subject.
Results
Table 1 shows the levels and distribution of
the variables used in this study, overall, and
for the different combinations of GSTM1
genotype and HMOX 1 microsatellite repeat
length. The study participants were all male,
with average age of 72.8 years (SD = 6.6 years)
at the first HRV measurement. No differences
among the subpopulations defined by the
combinations of GSTM1 genotype [wild-type
or null] and HMOX-1 microsatellite repeat
length [< 25 (GT)n repeats in both alleles or
≥ 25 (GT)n repeats in at least one allele] were
found in age, BMI, systolic blood pressure,
diastolic blood pressure, mean arterial pres-
sure, heart rate, fasting blood glucose, total
cholesterol, high-density lipoproteins (HDL),
triglyceride, smoking status, alcohol intake
(≥ 2 drinks/day), history of coronary heart dis-
ease (CHD), diabetes, hypertension, or stroke,
and use of beta-blockers, calcium channel
blockers, or ACE inhibitors (Table 1). The
two genes were not associated with each other
(p > 0.67).
Table 2 shows the results of the analyses
for the association of PM2.5 with changes in
HRV for the entire population (model 1), by
GSTM1 genotype (model 2), and by
HMOX-1 microsatellite (GT)n repeat length
(model 3).
For the entire population, we found that a
10 µg/m3 increase in ambient PM2.5 in the
48 hr before the HRV measurement was asso-
ciated with a 6.8% decrease in SDNN [95%
confidence interval (CI), –12.9 to –0.2; p =
0.043] and with a 17.3% decrease in HF
(95% CI, –30.0 to –2.3; p = 0.026). Ambient
PM2.5 concentrations were also negatively
associated with LF (estimated change =
–11.2%, 95% CI, –22.8 to 2.2), but the result
was not statistically significant (p = 0.10).
The PM2.5–HRV association was modi-
fied by GSTM1 genotype, with PM2.5 con-
centrations negatively associated with SDNN,
HF, and LF in GSTM1-null subjects, whereas
no association between PM2.5 and HRV was
found in GSTM1–wild-type carriers. In sub-
jects with the GSTM1-null deletion, a
10-µg/m3 increase in PM2.5 was associated
with a 10.5% decrease in SDNN (95% CI,
–18.2 to –2.2; p = 0.015), a 24.2% decrease
in HF (95% CI, –39.2 to –5.5; p = 0.014),
and a 17.0% decrease in LF (95% CI, –31.0
to –0.2; p = 0.048). In GSTM1–wild-type
subjects, the estimated decreases in HRV for a
10-µg/m3 increase in PM2.5 were 2.0% (95%
CI, –11.3 to 8.3; p = 0.69) for SDNN, 4.0%
(95% CI, –24.8 to 22.6; p = 0.74) for HF,
and 0.6% (95% CI, –19.0 to 22.0; p = 0.95)
for LF. However, the p-values for statistical
interactions between PM2.5 and GSTM1
genotype were not significant.
Similarly, we found that that PM2.5–HRV
association was modified by HMOX-1 geno-
types. Ambient PM2.5 concentrations were
negatively associated with all three HRV out-
comes in carriers of at least one allele with
≥ 25 microsatellite (GT)n repeats in the
HMOX-1 promoter region, whereas no associ-
ation between PM2.5 and HRV was present
in carriers of < 25 repeats in both alleles.
In subjects with at least one allele with
≥ 25 microsatellite (GT)n repeats, a 10-µg/m3
increase in PM2.5 was associated with a 8.5%
decrease in SDNN (95% CI, –14.8 to –1.8;
p = 0.014), a 20.1% decrease in HF (95% CI,
–32.9 to –5.0; p = 0.012), and a 14.0%
decrease in LF (95% CI, –25.7 to –0.5; p =
0.043).The p-value for statistical interactions
between PM2.5 and GSTM1 genotype was
marginally significant (p = 0.059) when the
SDNN component of HRV was considered
but was not significant for HF (p = 0.14) and
LF (p = 0.11).
We further evaluated the interrelationship
between PM2.5, GSTM1, and HMOX-1 by
estimating the effect of PM2.5 on HRV
within each combination of the GSTM1
genotypes and HMOX-1 microsatellite repeat
length categories (Table 3). These results
indicate a clear trend of increasingly negative
coefficients as we move across gene categories.
In carriers of both the GSTM1-null deletion
and at least one allele with ≥ 25 HMOX-1
microsatellite (GT)n repeats, PM2.5 was nega-
tively associated with all three HRV out-
comes, whereas no significant association was
found in subjects with any other combina-
tions. In subjects carrying the GSTM1-null
deletion and at least one allele with ≥ 25
HMOX-1 microsatellite (GT)n repeats, a
10-µg/m3 increase in PM2.5 in the 48 hr
before the HRV measurement was associated
with a –12.7% decrease in SDNN (95% CI,
–20.6 to –3.9; p = 0.0059), a 27.8% decrease
in HF (95% CI, –43.0 to –8.5; p = 0.0073),
and a 20.1% decrease in LF (95% CI, –34.5
to –2.7; p = 0.0261). GSTM1 genotypes and
HMOX-1 microsatellite repeat lengths had a
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Table 2. Adjusted percent change (95% CI) of heart rate variability (HRV) for each 10 µg/m3 of PM2.5 in the 48 hr before the measurement, by HMOX-1 micro-
satellite repeat length or GSTM1 polymorphism.
Model 2 Model 3
Model 1 PM2.5 effect by GSTM1 PM2.5 effect by HMOX-1 microsatellite length
HRV measurementa Main effect of PM2.5 GSTM1 wild-type GSTM1 null HMOX-1 < 25 repeatsb HMOX-1 ≥ 25 repeatsc
log10 SDNN –6.8% –2.0% –10.5% 7.4% –8.5%
(–12.9 to –0.2) (–11.3 to 8.3) (–18.2 to –2.2) (–8.7 to 26.2) (–14.8 to –1.8)
p = 0.0436 p = 0.6908 p = 0.0150 p = 0.3891 p = 0.0137
p-interaction = 0.1382 p-interaction = 0.0594
log10 HF –17.3% –4.0% –24.2% 8.9% –20.1%
(–30.0 to –2.3) (–24.8 to 22.6) (–39.2 to –5.5) (–27.1 to 62.8) (–32.9 to –5.0)
p = 0.0263 p = 0.7442 p = 0.0139 p = 0.6759 p = 0.0115
p-interaction = 0.1178 p-interaction = 0.1408
log10 LF –11.2% –0.6% –17.0% 14.0% –14.0%
(–22.8 to 2.2) (–19.0 to 22.0) (–31.0 to –0.2) (–18.6 to 59.5) (–25.7 to –0.5)
p = 0.0986 p = 0.9545 p = 0.0478 p = 0.4465 p = 0.0430
p-interaction = 0.1536 p-interaction = 0.1102
All models adjusted for age, BMI, mean arterial pressure, fasting blood glucose, cigarette smoking (never/former/current), alcohol consumption (two or more drinks a day, yes/no), use
of beta-blockers, use of calcium channel blockers, use of ACE inhibitor, room temperature, season, and 48-hr moving average of outdoor apparent temperature.
aStandard deviation of SDNN, power in HF (0.15–0.4 Hz) and LF (0.04–0.15 Hz) computed using a fast Fourier transform algorithm. bCarriers of < 25 microsatellite (GT) repeats in both
alleles. cCarriers of ≥ 25 microsatellite (GT) repeats in at least one allele.
combined effect on the association between
PM2.5 and HRV, as shown in Table 3 by the
significant three-way interaction term
between GSTM1, HMOX-1, and PM2.5
(coded as PM2.5 × a trend variable that is 1
for GSTM1 present and both short repeats, 2
for GSTM1 null and both short repeats, 2 for
one long repeat and GSTM1 present, and 4
for GSTM1 null and at least one long repeat).
To test whether the effect modification by
genotype was driven by a few individuals or
represented a more general shifting of the dis-
tribution of PM2.5–HRV slopes, we refit our
mixed models, dropping the interaction terms
with genotype but allowing for random sub-
ject-specific slopes. Figure 1 shows the distrib-
ution of subject-specific PM2.5 slopes for
SDNN by three categories of genotype
(HMOX-1 < 25 repeats and GSTM1 wt,
either HMOX-1 ≥ 25 repeats or GSTM1 null,
or both HMOX-1 ≥ 25 repeats and GSTM1
null). The shift to the left of the distributions
does not appear to be driven by outliers. The
same shift in the distributions was observed
also for the HF and LF components (data not
shown).
Goodness of fit of the three-way interac-
tion models was evaluated using the Akaike
Information Criterion (AIC). AICs for mod-
els including the three-way interaction term
were lower than those obtained from corre-
sponding models including the main effects
of GSTM1, HMOX-1, and PM2.5, as well as
the two-way interactions between GSTM1
and PM2.5 and HMOX-1 and PM2.5, thus
indicating better goodness of fit.
Discussion
Our study, based on an elderly population in
Boston, showed that functional genetic varia-
tions in GSTM1 and HMOX-1, both of
which are related to defenses against oxidative
stress, modify the effects of PM2.5 on HRV.
In the present work, we have extended our
previous results examining the modification
of the PM2.5–HRV association by GSTM1
(Schwartz et al. 2005b) to include other HRV
outcomes and repeated measures on subjects,
to show effect modification by HMOX-1, and
to show a three-way interaction between the
two genes and combustion particles.
This work is part of a series of studies
seeking to examine the potential pathways by
which particles affect HRV. Specifically, we
are looking at oxidative stress and endothelial
function as potential pathways to this out-
come. We hypothesize that if a pathway is
important in the effect of PM2.5 on HRV,
then factors that modify that pathway, either
genes or drugs, may modify the PM2.5
response. We are also looking at metal-pro-
cessing pathways as an indirect test of the
hypothesis that metals on the PM2.5 particles
play an important role in the HRV response
(Park et al. 2006).
In our previous work on the same popula-
tion we showed that ambient PM2.5 concen-
trations averaged over the 48 hr before the
examination were associated with a reduction
HF, with negative, albeit nonsignificant, asso-
ciations were seen with SDNN and LF (Park
et al. 2005). In the present work, based on
longer follow-up and additional HRV meas-
urements, we were also able to show a signifi-
cant effect on SDNN, as well as a more
pronounced, although still nonsignificant,
negative association with LF.
As part of our examination of oxidative
stress we have previously shown that particles
had no effect on HRV in subjects with the
functional GSTM1 polymorphism (GSTM1–
wild-type) but had a substantially increased
effect in those with the deletion (GSTM1-null)
(Schwartz et al. 2005b). Similarly, we showed
that statin use and obesity, which both modify
ROS production, altered PM2.5 effects on
HRV (Schwartz et al. 2005b), thus confirming
the critical role of oxidative stress pathways. In
this article, we extend those results by showing
a three-way interaction with genetic modifiers
of response to oxidative stress.
Although particle exposure has also been
linked with activation of inflammatory path-
ways (Baccarelli et al. 2007b; Liao et al. 2004;
Peters et al. 2001), alterations in blood coagu-
lation (Baccarelli et al. 2007a; Liao et al.
2005), endothelial injury and dysfunction
(Brook et al. 2002; Ikeda et al. 1998), and
alterations in the autonomic control of the
heart (Creason et al. 2001; Gold et al. 2000;
Liao et al. 2004a), our findings suggest that
genetic variations in oxidative stress pathways
play a critical role in the cardiovascular effects
of airborne particles.
Rodents exposed to concentrated urban
particles evinced increased reactive oxygen
species in both the lung and the heart
(Gurgueira et al. 2002), an effect muted by
preadministration of N-acetylcysteine, a glu-
tathione precursor and potent antioxidant
(Rhoden et al. 2004). Inhalation of particles
produces oxidative stress directly or via acute
pulmonary inflammation, thus causing a
series of events, such as the production of
proinflammatory mediators, an increase of
extracellular calcium influx, and the disrup-
tion of nitric oxide regulation (Stone et al.
2000; Thomas et al. 2001), that may impair
autonomic function and hence HRV. Diesel
particles have also been shown to increase
oxidative stress in endothelial tissue, inducing
the production of HMOX-1 (Furuyama et al.
2006). The viability of cell cultures of
microvascular endothelial cells was impaired
by diesel particles with an accompanying large
increase in induction of HMOX-1 (Hirano
et al. 2003); this process was blunted by
N-acetylcysteine. Woodsmoke particles have
also been shown to deplete intracellular glu-
tathione and upregulate HMOX-1 activity in
Chahine et al.
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Table 3. Effect modification of HMOX-1 microsatellite repeat length and GSTM1 combinations on the adjusted percent change (95% CI) of HRV for each 10 µg/m3
of PM2.5 in the 48 hr before the measurement.
HMOX-1 < 25 repeatsb HMOX-1 < 25 repeatsb and GSTM1 null or
GSTM1 wild-type HMOX-1 ≥ 25 repeatsc and GSTM1 wild-type HMOX-1 ≥ 25 repeatsc GSTM1 null
HRV measurementa (no. of visits = 26d) (no. of visits = 309d) (no. of visits = 303d) Test for interaction
Log10 SDNN 28.7% (–12.0 to 88.2) –2.7% (–11.5 to 6.8) –12.7% (–20.6 to –3.9) p = 0.0084
p = 0.1937 p = 0.5620 p = 0.0059
Log10 HF 45.6% (–43.5 to 275.3) –5.8% (–25.3 to 18.8) –27.8% (–43.0 to –8.5) p = 0.0108
p = 0.4370 p = 0.6153 p = 0.0073
Log10 LF 68.5% (–23.3 to 270.4) –2.8% (–19.9 to 18.0) –20.1% (–34.5 to –2.7) p = 0.0385
p = 0.1944 p = 0.7722 p = 0.0261
All models adjusted for age, BMI, mean arterial pressure, fasting blood glucose, cigarette smoking (never/former/current), alcohol consumption (two or more drinks a day, yes/no), use
of beta-blockers, use of calcium channel blockers, use of ACE inhibitor, room temperature, season, and 48-hr moving average of outdoor apparent temperature.
aStandard deviation of SDNN, power in HF (0.15–0.4 Hz) and LF (0.04–0.15 Hz) computed using a fast Fourier transform algorithm. bCarriers of < 25 microsatellite (GT) repeats in both alle-
les. cCarriers of ≥ 25 microsatellite (GT) repeats in at least one allele. dNumber of HRV measurements.
Figure 1. Kernel density plot of subject-specific
random slopes for the association of PM2.5 level
with SDNN, by GSTM1 genotype and HMOX-1
repeat length.
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endothelial cells (Liu et al. 2005). Our results
showing interactions of particles with
GSTM1 deletion and microsatellite (GT)n
repeat length in the gene coding for
HMOX-1 are consistent with these laboratory
findings that suggest a prominent role of ROS
in particle toxicity.
HMOX-1, the inducible heme oxygenase
isoform, is expressed in multiple tissues,
including vascular smooth muscle and
endothelial cells (Exner et al. 2004). HMOX-1
expression has been shown to be upregulated
in rat heart microvessel endothelial cells
exposed to organic extracts of diesel exhaust
particles (Furuyama et al. 2006), an effect that
is likely to represent a response directed
against ROS production (Morita 2005). Large
individual differences in the ability to modu-
late the quantitative level of HMOX-1 activity
in response to a given stimulus have been
described, which correlate with differences in
the length of a microsatellite (GT)n repeat in
the 5´ flanking region of the HMOX-1 gene
(Exner et al. 2004; Hirai et al. 2003; Yamada
et al. 2000). The purine–pyrimidine alternat-
ing sequence in the (GT)n repeat has the
potential to assume Z-DNA conformation, a
left-handed double-helix structure that is ther-
modynamically unfavorable compared with
B-DNA conformation (Rich et al. 1984) and
has been described as negatively affecting tran-
scriptional activity (Delic et al. 1991; Naylor
and Clark 1990). Yamada and co-workers
demonstrated by transient-transfection assay in
cultured cell lines that the larger the number
of (GT)n repeats in the HMOX-1 gene pro-
moter, the lower is the HMOX-1 inducibility
by ROS (Yamada et al. 2000).
In our study, HMOX-1 microsatellite
(GT)n repeat length appeared to modulate
the effects of PM2.5 on autonomic function,
as measured by HRV variability. PM2.5 exhib-
ited a negative correlation with SDNN, HF,
and LF in individuals with ≥ 25 repeats,
whereas no effect was seen in subjects with
< 25 repeats. Furthermore, the strongest
effects of PM2.5 were found in subjects that
were lacking efficiency in antioxidant
responses due to the combination of the
GSTM1 deletion and ≥ 25 microsatellite
(GT)n repeats in the HMOX-1 promoter.
While the p-values for statistical interaction
between PM2.5 and GSTM1 and between
PM2.5 and HMOX-1 were not significant, the
tests for the three-way interaction among
PM2.5, GSTM1, and HMOX-1 were highly
significant, confirming that the stronger effect
modification of PM2.5 effects on HRV is seen
when both genes are considered. The statisti-
cal modeling we used to fit the three-way
interaction tested whether the size of PM2.5
effects in carriers of GSTM1 null and at least
one long HMOX-1 repeat was 2 times larger
than that observed in subjects carrying either
GSTM1 null or one long HMOX-1 repeat.
Thus, our data strongly suggest that particle
exposure interacts with individual variations
in the antioxidant response pathway to deter-
mine its effects on HRV.
A potential limitation of this study is that
we used ambient PM2.5 concentrations from a
single monitoring site as a surrogate for recent
exposure to PM2.5. A recent study comparing
ambient concentrations at this site with per-
sonal exposures in Boston has shown a high
longitudinal correlation (Sarnat et al. 2005)
between the two measurements; the study also
reported that PM2.5 concentrations were spa-
tially homogeneous over the Boston area. This
suggests that our use of ambient concentrations
is reasonable and the resulting exposure error is
likely to be nondifferential. In our analyses, we
considered several potential confounding fac-
tors that may have influenced HRV measures,
as we adjusted our models for age, BMI, mean
arterial pressure, fasting blood glucose, ciga-
rette smoking, alcohol consumption, room
temperature, outdoor apparent temperature,
season, and use of beta-blockers, calcium chan-
nel blockers, and ACE inhibitors. Therefore,
chances that the observed associations reflected
bias due to confounders are minimized. 
Our results can be generalized only to an
aged population that consists of older males
who are almost all white. The effect on
women and children as well as different ethnic
groups should be addressed in future studies,
particularly in relation to the exposure of
different population groups to PM2.5 with
varying geographic location, occupation,
socioeconomic status, and behavioral charac-
teristics. Other health outcomes including res-
piratory responses may also be affected by
responses to ROS in an interaction with
PM2.5 exposure. Our findings provide new
information to guide research on the breadth
of the effect of PM2.5 exposure.
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